Belimumab in Lupus Nephritis

被引：1

作者：

Rojas-Rivera, Jorge ^{[1
]}

Ortiz, Alberto ^{[1
]}

Carriazo, Sol ^{[1
]}

机构：

[1] Hosp Univ Fdn Jimenez Diaz, Madrid, Spain

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2021年 / 384卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

To the Editor: Furie et al. (Sept. 17 issue)(1) report the results of the Belimumab International Study in Lupus Nephritis (BLISS-LN), a large, randomized trial of intravenous belimumab as compared with placebo when added to standard therapy (mycophenolate mofetil or cyclophosphamide-azathioprine) in adults with active lupus nephritis. There was adequate follow-up time, but several points need clarification. Notably, one third of the patients were not taking a renin-angiotensin system (RAS) blocker at baseline. Although initiation of an RAS blockade was encouraged, it would have to have been initiated before week 24; treatment would otherwise be considered to have failed. Since . . .

引用

页码：187 / 187

页数：1

共 50 条

[21] Urine proteomic insights from the belimumab in lupus nephritis trial
Weeding, Emma
Fava, Andrea
Mohan, Chandra
Magder, Laurence
Goldman, Daniel
Petri, Michelle
LUPUS SCIENCE & MEDICINE, 2022, 9 (01):
[22] B-cell depletion or belimumab or voclosporin for lupus nephritis?
Lei, Yutian
Loutan, Jerome
Anders, Hans-Joachim
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2021, 30 (02): : 237 - 244
[23] Rituximab-refractory lupus nephritis successfully treated with belimumab
Gonzalez-Echavarri, C.
Ugarte, A.
Ruiz-Irastorza, G.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (02) : 355 - 356
[24] De novo lupus nephritis in patients receiving belimumab therapy
Parodis, I.
Vital, E. M.
Jonsen, A.
Hassan, S. U.
Leonard, D.
Eriksson, P.
Bengtsson, A. A.
Gunnarsson, I.
Ronnblom, L.
Sjowall, C.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2021, 50 : 41 - 42
[25] The efficacy of rituximab plus belimumab or telitacicept in refractory lupus nephritis
Chen, Yiting
Shi, Nan
Lei, Xin
Ren, Pingping
Lan, Lan
Chen, Liangliang
Wang, Yaomin
Xu, Ying
Lin, Yuxin
Chen, Jianghua
Han, Fei
RHEUMATOLOGY, 2023,
[26] SUCCESSFUL TREATMENT OF LUPUS NEPHRITIS WITH BELIMUMAB AND VOCLOSPORIN: A RARE CASE
Ebrahimi, Niloufar
Ghozloujeh, Zohreh Gholizadeh
Momand, David
Abdipour, Amir
Norouzi, Sayna
AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (04) : S16 - S16
[27] Efectiveness of belimumab in the treatment of lupus nephritis: analysis of 8 cases
de la Rubia Navarro, Marta
Ivorra Cortes, Jose Rafael
Grau Garcia, Elena
Roman Ivorra, Jose Andres
MEDICINA CLINICA, 2022, 159 (07): : 344 - 346
[28] Efficacy and Safety of Belimumab in Severe Lupus Nephritis: A Retrospective SingleCenter Study
Aierken, Ailima
Zhuang, Jing
Yang, Shufen
Yalikun, Dilina
Xu, Chengren
Zhang, Changrong
Tian, Xuefei
Jiang, Hong
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
[29] Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
Furie, Richard
Rovin, Brad H.
Houssiau, Frederic
Malvar, Ana
Teng, Y. K. Onno
Contreras, Gabriel
Amoura, Zahir
Yu, Xueqing
Mok, Chi-Chiu
Santiago, Mittermayer B.
Saxena, Amit
Green, Yulia
Ji, Beulah
Kleoudis, Christi
Burriss, Susan W.
Barnett, Carly
Roth, David A.
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (12): : 1117 - 1128
[30] Longitudinal modeling of efficacy response in patients with lupus nephritis receiving belimumab
Simeoni, Monica
Yang, Shuying
Tompson, Debra J.
Dimelow, Richard
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2024, 51 (03) : 289 - 301

← 1 2 3 4 5 →